1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Non-metastatic Soft-tissue Sarcoma: new trials by email Literature Review of Non-metastatic Soft-tissue Sarcoma trials Research Report on Non-metastatic Soft-tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the investigator - Non-metastatic Soft-tissue Sarcoma, Resectable | Phase 3 | Recruiting | Institut Bergonié | 351 | 2019-02-14 | 2025-10-02 |
Sarcoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1)
Dacarbazine (1) · Doxorubicin (1) · Ifosfamide (1)
France (1)
2018 (1)